India is currently hit hard by Covid-19 pandemic and is preparing a vaccine that will soon be tested on patients.
Coronavirus pandemic still afflicts the entire planet but India is close to producing a vaccine for covid-19. It is not expected to be released until the end of 2020, but India has announced that it will release its own vaccine for COVID-19 on August 15, known as Covaxin.
The Council of Medical Research (ICMR) is developing this vaccine in collaboration with Bharat Biotech International (BBIL). As it became known, the ICMR has already found medical colleges and hospitals where rapid clinical trials for the vaccine will be carried out.
The 12 institutes selected for the clinical trial are located in new Delhi, Rohtak, Patna, Belgaum, Nagpur, Gorakhpur, Visakhapatnam, Kattankulathur, Hyderabad, Arya Nagar, Kanpur, Goa and Bhubaneswar.
Covaxin is developed and manufactured at the BBIL facility in the Genome Valley in Hyderabad. This is the first vaccine to get the approval of India’s Drug Controller to pass the clinical trial phase in humans. Currently only two manufacturers in India have been given the green light to proceed with the creation of the vaccine.
- Personal Computer in battle against coronavirus pandemic
- Greek company brings first disinfection robot to market
- Google gives $1 million to Greece to tackle coronavirus
However, ICMR’s Covaxin has raised a number of concerns, with many believing that developing a vaccine in such a short period of time can pose a risk to public health. Usually, developing a vaccine takes a long time as there are many phases involved in this process.
But due to the fact that India is in fourth place on the list of most cases of coronavirus worldwide, it makes sense for the country to be in a hurry to release a vaccine as soon as possible.